BRUSSELS, BELGIUM / RankWire.AI / – The European Commission has broadened its efforts to combat Ebola by ordering €2.1 million worth of PCR tests specifically for the Bundibugyo virus outbreak. This initiative includes open-platform testing kits that laboratories can utilize with their current infrastructure. The procurement process was supported by the European Health and Digital Executive Agency. Shipments are scheduled to commence in August, as health teams address a significant outbreak concentrated in the Democratic Republic of the Congo and extending into surrounding areas.
The World Health Organization will facilitate the distribution of these tests through its Hub for Global Health Emergencies Logistics in Dubai. From there, WHO will coordinate the distribution to various locations involved in the Ebola response. PCR testing enables laboratories to verify infections and bolster surveillance efforts around known cases. Confirmed results are used by health teams to inform patient treatment, isolation protocols, and contact tracing activities. This latest batch of supplies enhances laboratory capabilities at a crucial time when authorities are monitoring ongoing transmission across multiple provinces and health zones within the Democratic Republic of the Congo.
Previously, the European Commission arranged a package worth €2.5 million consisting of rapid molecular point-of-care tests and testing devices. That equipment is intended to support the Africa Centres for Disease Control and Prevention in their regional response efforts. Together, these diagnostic agreements total €4.6 million. They form part of a larger package of European aid designed to assist countries affected by the Bundibugyo Ebola emergency. The assistance encompasses medical supplies, preparedness strategies, and public health resources aimed at strengthening responses in both affected and neighboring regions.
Testing capacity expands amid a severe outbreak
According to WHO figures, the Democratic Republic of the Congo had reported 4,665 confirmed cases and 2,184 deaths by August 12. The authorities identified infections across 54 health zones in six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO characterized the epidemic as the largest Ebola outbreak ever recorded in the country. The agency also noted ongoing transmission within connected geographic clusters, which continues to place high demands on surveillance teams, laboratories, treatment centers, and local health services.
In its August update, WHO maintained a very high national risk level for the Democratic Republic of the Congo. It also classified the risk for neighboring countries as high, while assessing the global risk as low. Following a meeting of its International Health Regulations Emergency Committee on August 24, WHO issued updated temporary guidelines covering surveillance, case detection, infection prevention, clinical management, and community engagement. The recommendations additionally address public health measures related to mobility and large gatherings amid the ongoing response efforts.
European health aid totals €493 million
The European Commission announced the mobilization of €493 million for emergency aid, vaccines, treatment, and health security measures across the Great Lakes region and Uganda. European health agencies have also contributed to laboratory operations, surveillance, and preparedness activities. The European Centre for Disease Prevention and Control continues to consider the risk to European populations as very low. Since Ebola spreads primarily through direct contact with infected bodily fluids, rapid detection, safe clinical practices, and stringent infection control are vital in limiting further transmission.
The Bundibugyo virus outbreak remains a public health emergency of international concern under WHO’s international health framework. Currently, no approved vaccine or specific treatment exists for Bundibugyo virus disease. Consequently, health authorities continue to depend on surveillance, swift diagnosis, patient isolation, clinical care, infection prevention, and close contact monitoring. The new PCR testing capacity enhances these efforts, with WHO, Africa CDC, and national health agencies coordinating their responses to quickly identify cases and sustain public health measures in affected communities.